Skip to main content
. Author manuscript; available in PMC: 2021 Apr 24.
Published in final edited form as: Oral Oncol. 2020 Aug 29;111:104981. doi: 10.1016/j.oraloncology.2020.104981

Table 1.

Comparison of characteristics among patients diagnosed with HPV16 positive-oropharynx cancer (PROVE study) and healthy individuals with detectable oral HPV16 DNA (NHANES). IQR = Interquartile range.

Patient Characteristics HPV16-OPC
n = 131
Oral HPV16 in healthy individuals
n = 159
P-value
N % N %
Age (in years): < 0.001
 18 – 29 1 0.8 25 15.7
 30 – 39 3 2.3 30 18.9
 40 – 49 25 19.1 34 21.4
 50 – 59 60 45.8 38 23.9
 60 – 69 42 32.1 32 20.1
Sex 0.99
 Male 112 85.5 136 85.5
 Female 19 14.5 23 14.5
Race and Ethnicity < 0.001
 White non-Hispanic 116 88.5 83 52.2
 Black non-Hispanic 8 6.1 35 22.0
 Hispanic any race 4 3.1 31 19.5
 Other 3 2.3 10 6.3
Cigarette Use (n = 157) < 0.001
 Never 62 47.3 59 37.6
 Current 9 6.9 66 42.0
 Former 60 45.8 32 20.4
Alcohol Use (n = 111) (n = 159) < 0.001
 Never 2 1.8 2 1.3
 Current 57 51.4 121 76.1
 Former 52 46.8 36 22.6
Ever Illegal Drug Use (n = 130) (n = 145) < 0.001
 No 25 19.2 95 65.5
 Yes 105 80.8 50 34.5
Lifetime Sex Partners (n = 144) 0.06
 Median (IQR) 20 (8 – 45) 15 (6 – 35)
Lifetime Oral Sex Partners (n = 112) 0.17
 Median (IQR) 10 (4 – 25) 8.5 (3 – 25.5)
Lifetime Vaginal Sex Partners (n = 125) (n = 109) 0.1
 Median (IQR) 20 (8 – 35) 15 (6 – 30)